Rezultati

eNauka >  Results >  Impact of switching from BRAF/MEK inhibition to immune checkpoint inhibition before secondary resistance in metastatic melanoma: A EUMelaReg real-world study
Title: Impact of switching from BRAF/MEK inhibition to immune checkpoint inhibition before secondary resistance in metastatic melanoma: A EUMelaReg real-world study
Authors Weichenthal, M; ...; Kandolf-Sekulovic, L; ...; (broj, koautora 20)
Issue Date: 2025
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 36 str. S963-S964
DOI: 10.1016/j.annonc.2025.08.2251
WoS-ID: 001634626200023
URI: https://enauka.gov.rs/handle/123456789/1019103
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.